InBody
Key metrics
Earnings
| Revenue, Q3 2026 | ₩71.3bn |
|---|---|
| Revenue QoQ | -2.7% |
| Revenue YoY | +19.2% |
| Operating income, Q3 2026 | ₩19.3bn |
| Operating income QoQ | +8.9% |
| Operating income YoY | +96.5% |
Share buybacks
| Buyback decided, last 3 months | ₩0 |
|---|---|
| Buyback decided, last 3 months, % of shares | 0.0% |
| Shares acquired, last 3 months | ₩0 |
| Shares acquired, last 3 months, % of shares | 0.0% |
| Treasury shares cancelled, last 3 months | ₩0 |
| Treasury shares cancelled (number), last 3 months | 0 shares |
| Treasury shares cancelled, last 3 months, % of shares | 0.0% |
| Buyback decided, last 12 months | ₩0 |
| Buyback decided, last 12 months, % of shares | 0.0% |
| Shares acquired, last 12 months | ₩0 |
| Shares acquired, last 12 months, % of shares | 0.0% |
| Treasury shares cancelled, last 12 months | ₩0 |
| Treasury shares cancelled (number), last 12 months | 0 shares |
| Treasury shares cancelled, last 12 months, % of shares | 0.0% |
Potential dilution
| CB/BW/EB issued, last 12 months | ₩0 |
|---|---|
| Rights offering new shares, last 12 months | 0 shares |
| Potential new shares, last 12 months | 0 shares |
| Potential new shares, % of shares | 0.0% |
| Conversion price adjustments, last 12 months | 0 |
Supply contracts
| Supply contracts, last 12 months | ₩0 |
|---|---|
| Supply contracts vs prior-year revenue | 0.0% |
| Contracts without a KRW amount | 0 contracts without a KRW amount excluded |
Disclosure activity
| DART filings, last 3 months | 9 |
|---|---|
| DART filings, previous 3 months | 10 |
Insider transactions
| Open-market buys, last 12 months (shares) | 0 shares |
|---|---|
| Open-market buys, last 12 months (amount) | ₩0 |
| Open-market sells, last 12 months (shares) | 0 shares |
| Open-market sells, last 12 months (amount) | ₩0 |
| Net open-market buying, last 12 months (shares) | 0 shares |
| Insiders who bought, last 12 months | 0 |
Insider transactions (last 12 months)
Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.
| Trade date | Insider (role) | Type | Shares | Price | Amount | |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Cha In-jun (Registered director) | Other (After-hours sell) | -120,000 shares | ₩54,860 | ₩6.6bn | |
| May 21, 2026 | Bang U Seong (Registered director) | Other (Treasury stock bonus) | +300 shares | — | — | |
| Jan 1, 2026 | Kim Do-seong (Non-registered officer) | Other (New appointment) | +32 shares | — | — | Reported late |
Annual financials
| Year | Revenue | Operating income |
|---|---|---|
| 2025 | ₩233.9bn | ₩36.8bn |
| 2024 | ₩204.5bn | ₩36.7bn |
| 2023 | ₩170.4bn | ₩38.3bn |
Filing timeline
-
InBody Plans Disposal of 1,658 Treasury Shares Worth ₩77m
InBody filed on Nov 5, 2026 to dispose of 1,658 treasury shares for a planned amount of ₩77m. The stated purpose is employee performance compensation, and the planned amount is less than 0.1% of FY2025 revenue by our calculation.